Charles River Labs Intl buy JPMorgan Chase & Co.
Start price
15.02.24
/
50%
€227.80
Target price
15.02.25
€259.70
Performance (%)
-6.85%
Price
09.05.24
€212.20
Summary
This prediction is currently active. With a performance of -6.85%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 15.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | -2.167% | -2.167% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $270.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€211.90
20.12.23
20.12.23
€246.65
20.12.24
20.12.24
0.14%
09.05.24
09.05.24
Charles River Labs Intl
Start price
Target price
Perf. (%)
€198.20
10.08.23
10.08.23
€227.00
10.08.24
10.08.24
7.06%
09.05.24
09.05.24